[1]
|
左婷婷, 郑荣寿, 曾红梅, 等. 中国胃癌流行病学现状[J]. 中国肿瘤临床, 2017, 44(1): 52-58.
|
[2]
|
Joshi, S.S. and Badgwell, B.D. (2021) Current Treatment and Recent Progress in Gastric Cancer. CA: A Cancer Journal for Clinicians, 71, 264-279. https://doi.org/10.3322/caac.21657
|
[3]
|
Wanebo, H.J., Kennedy, B.J., Chmiel, J., Steele, G., Winchester, D. and Osteen, R. (1993) Cancer of the Stomach. A Patient Care Study by the American College of Surgeons. Annals of Surgery, 218, 583-592. https://doi.org/10.1097/00000658-199321850-00002
|
[4]
|
Lin, Y., Docherty, S.L., Porter, L.S. and Bailey, D.E. (2020) Common and Co-Occurring Symptoms Experienced by Patients with Gastric Cancer. Oncology Nursing Forum, 47, 187-202. https://doi.org/10.1188/20.ONF.187-202
|
[5]
|
Wu, H., Wang, W., Tong, S., et al. (2015) Nucleostemin Regulates Proliferation and Migration of Gastric Cancer and Correlates with Its Malignancy. International Journal of Clinical and Experimental Medicine, 8, 17634-17643.
|
[6]
|
彭智, 沈琳. 晚期胃癌综合治疗理念更新[J]. 中国实用外科杂志, 2017, 37(10): 1078-1082. https://doi.org/10.19538/j.cjps.issn1005-2208.2017.10.03
|
[7]
|
胡月新. 多西他赛联合奥沙利铂及氟尿嘧啶治疗晚期胃癌的临床研究[J]. 黑龙江医药, 2009, 22(4): 477-479.
|
[8]
|
Ergen, S.A., Oksüz, D.C., Karacam, S. and Dıncbas, F.O. (2021) Management of IMRT in a Gastric Cancer Patient with Pacemaker: A Case Report and Review of the Literature. Journal of Cancer Research and Therapeutics, 17, 1559-1561. https://doi.org/10.4103/jcrt.JCRT_430_19
|
[9]
|
Taniguchi, H., Kimura, Y., Kim, C., Danno, K., Kagara, N., Kanoh, T., Yoshida, T., Ohnishi, T., Tohno, T., Yamada, Y., Kagawa, K., Monden, T. and Imaoka, S. (2012) Effects of Stereotactic Radiotherapy Targeting for Recurrent Gastric Cancer. Gan to Kagaku Ryoho, 39, 2313-2315.
|
[10]
|
Khrizman, P., Small, W., Dawson, L. and Benson, A.B. (2010) The Use of Stereotactic Body Radiation Therapy in Gastrointestinal Malignancies in Locally Advanced and Metastatic Settings. Clinical Colorectal Cancer, 9, 136-143. https://doi.org/10.3816/CCC.2010.n.018
|
[11]
|
Jácome, A.A., Sankarankutty, A.K. and Dos Santos, J.S. (2015) Adjuvant Therapy for Gastric Cancer: What Have We Learned since INT0116? World Journal of Gastroenterology, 21, 3850-3859. https://doi.org/10.3748/wjg.v21.i13.3850
|
[12]
|
Verma, V., Lin, S.H., Simone, C.B., et al. (2016) Clinical Outcomes and Toxicities of Proton Radiotherapy for Gastrointestinal Neoplasms: A Systematic Review. Journal of Gastrointestinal Oncology, 7, 644-664. https://doi.org/10.21037/jgo.2016.05.06
|
[13]
|
Catanese, S. and Lordick, F. (2021) Targeted and Immunotherapy in the Era of Personalised Gastric Cancer Treatment. Best Practice & Research Clinical Gastroenterology, 50-51, Article ID: 101738. https://doi.org/10.1016/j.bpg.2021.101738
|
[14]
|
Mitani, S. and Kawakami, H. (2020) Emerging Targeted Therapies for HER2 Positive Gastric Cancer That Can Overcome Trastuzumab Resistance. Cancers (Basel), 12, Article No. 400. https://doi.org/10.3390/cancers12020400
|
[15]
|
Matsuoka, T. and Yashiro, M. (2021) Molecular-Targeted Therapy toward Precision Medicine for Gastrointestinal Caner: Current Progress and Challenges. World Journal of Gastrointestinal Oncology, 13, 366-390. https://doi.org/10.4251/wjgo.v13.i5.366
|
[16]
|
Feng, R., Zhang, X. and Yang, S. (2016) Research Status Quo and Progression in Targeted Therapy for Advanced Gastric Cancer. Chinese Journal of Gastrointestinal Surgery, 19, 1191-1196.
|
[17]
|
Li, Y., Wang, C., Xu, M., et al. (2017) Preoperative NLR for Predicting Survival Rate after Radical Resection Combined with Adjuvant Immunotherapy with CIK and Postoperative Chemo-Therapy in Gastric Cancer. Journal of Cancer Research and Clinical Oncology, 143, 861-871. https://doi.org/10.1007/s00432-016-2330-1
|
[18]
|
Wu, Y.X., Zhou, X.Y., Wang, J.Q., Chen, G.M., Chen, J.X., Wang, R.C., Huang, J.Q. and Chen, J.S. (2023) Application of Immune Checkpoint Inhibitors in Immunotherapy for Gastric Cancer. Immunotherapy, 15, 101-115. https://doi.org/10.2217/imt-2022-0080
|
[19]
|
Zeng, Z., Yang, B. and Liao, Z. (2021) Progress and Prospects of Immune Checkpoint Inhibitors in Advanced Gastric Cancer. Future Oncology, 17, 1553-1569. https://doi.org/10.2217/fon-2020-0829
|
[20]
|
Zhu, Y., Zhu, X., Wei, X., Tang, C. and Zhang, W. (2021) HER2-Targeted Therapies in Gastric Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1876, Article ID: 188549. https://doi.org/10.1016/j.bbcan.2021.188549
|
[21]
|
Xing, R., Zhou, Y., Yu, J., Yu, Y., Nie, Y., Luo, W., Yang, C., Xiong, T., Wu, W.K.K., Li, Z., Bing, Y., Lin, S., Zhang, Y., Hu, Y., Li, L., Han, L., Yang, C., Huang, S., Huang, S., Zhou, R., Li, J., Wu, K., Fan, D., Tang, G., Dou, J., Zhu, Z., Ji, J., Fang, X. and Lu, Y. (2019) Whole-Genome Sequencing Reveals Novel Tandem-Duplication Hotspots and a Prognostic Mutational Signature in Gastric Cancer. Nature Communications, 10, Article No. 2037. https://doi.org/10.1038/s41467-019-09644-6
|
[22]
|
Xiang, Y.Y., Deng, C.C., Liu, H.Y., Kuo, Z.C., Zhang, C.H. and He, Y.L. (2022) The Prognostic Effect of Multidisciplinary Team Intervention in Patients with Advanced Gastric Cancer. Current Oncology, 29, 1201-1212. https://doi.org/10.3390/curroncol29020102
|
[23]
|
Schenk, T. and Scheithauer, W. (1993) Advances in the Prevention and Therapy of Common Chemotherapy-Induced Side Effects. Deutsche Medizinische Wochenschrift, 118, 831-837. https://doi.org/10.1055/s-2008-1059395
|
[24]
|
Chung, J., Ju, G., Yang, J., Jeong, J., Jeong, Y., Choi, M.K., Kwon, J., Lee, K.H., Kim, S.T. and Han, H.S. (2018) Prevalence of and Factors Associated with Anxiety and Depression in Korean Patients with Newly Diagnosed Advanced Gastrointestinal Cancer. The Korean Journal of Internal Medicine, 33, 585-594. https://doi.org/10.3904/kjim.2016.108
|
[25]
|
Breitbart, W., Rosenfeld, B., Pessin, H., Applebaum, A., Kulikowski, J. and Lichtenthal, W.G. (2015) Meaning-Centered Group Psychotherapy: An Effective Intervention for Improving Psychological Well-Being in Patients with Advanced Cancer. Journal of Clinical Oncology, 33, 749-754. https://doi.org/10.1200/JCO.2014.57.2198
|
[26]
|
Bozzetti, F. (2013) Nutritional Support of the Oncology Patient. Critical Reviews in Oncology/Hematology, 87, 172-200. https://doi.org/10.1016/j.critrevonc.2013.03.006
|
[27]
|
Matsuoka, T. and Yashiro, M. (2018) Biomarkers of Gastric Cancer: Current Topics and Future Perspective. World Journal of Gastroenterology, 24, 2818-2832. https://doi.org/10.3748/wjg.v24.i26.2818
|
[28]
|
Yamamoto, H., Adachi, Y., Taniguchi, H., Kunimoto, H., Nosho, K., Suzuki, H. and Shinomura, Y. (2012) Interrelationship between Microsatellite Instability and MicroRNA in Gastrointestinal Cancer. World Journal of Gastroenterology, 18, 2745-2755. https://doi.org/10.3748/wjg.v18.i22.2745
|
[29]
|
Onoyama, T., Ishikawa, S. and Isomoto, H. (2022) Gastric Cancer and Genomics: Review of Literature. Journal of Gastroenterology, 57, 505-516. https://doi.org/10.1007/s00535-022-01879-3
|
[30]
|
Mihaljevic, A.L., Friess, H. and Schuhmacher, C. (2013) Clinical Trials in Gastric Cancer and the Future. Journal of Surgical Oncology, 107, 289-297. https://doi.org/10.1002/jso.23120
|